Professor Anthony Maraveyas
I am a Professor in Oncology medicine (cancer) and my special interests are Renal (kidney) cancer, Pancreatic cancer, biliary tree cancer, liver cancer, malignant melanoma and thrombosis in cancer patients.
I graduated from Athens Medical School in 1983 and completed my medical training in internal medicine in 1990. In 1995 I was awarded a PhD from the University of London on the application of radiolabeled monoclonal antibodies in the treatment of head and neck cancer. I subsequently became a lecturer at St George’s Hospital Medical School studying the application of allogeneic vaccines in Melanoma. I was appointed Senior Lecturer in Medical Oncology at the University of Hull in 1999, helping establish the cancer services for HEYCCN (Humber and East Yorkshire Coast Cancer Network) and the new Medical School of HYMS (Hull York Medical School). I was promoted to Reader in HYMS and subsequently Professor of Medical Oncology. I treat gastrointestinal cancers studying the impact of thrombosis on these patients, and have been PI for many trials in melanoma and renal cell carcinoma including being Co-I for the STAR trial in RCC. My basic research interests include the targeting of cancer neo-vasculature and the haemostatic apparatus to interfere with cancer metastasis.
Some of the principal treatments carried out by Professor Anthony Maraveyas at Spire include:
Oesophageal, stomach and pancreas cancer (treatment options), melanoma, renal, colon, pancreatic/billary and liver cancer.
Spire Hull and East Riding Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
Consultant Oncologist Hull University Teaching Hospitals NHS Trust.
Honorary Senior Lecturer University of Hull.